China's Healthcare Security Administration says the country will not include Paxlovid in an update to its list of medicines covered by basic medical insurance schemes as the US firm quoted a high price for the drug.

While Paxlovid is widely available in many rich countries, availability has been severely restricted in poorer ones, echoing the disparities in the global Covid-19 response.